Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended
	May 27, 2023	May 28, 2022
Operating Activities
Net earnings	$ 23,576	$ 22,731
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	10,282	10,849
Share-based compensation	2,178	1,597
Deferred income taxes	(165)	4,400
Gain on disposal of assets	(27)	(660)
Proceeds from New Markets Tax Credit transaction, net of deferred costs	0	18,390
Settlement of New Markets Tax Credit transaction	0	(19,523)
Noncash lease expense	2,714	3,088
Other, net	(432)	952
Changes in operating assets and liabilities:
Receivables	(13,476)	(18,468)
Inventories	(2,068)	(17,744)
Contract assets	14,368	(13,528)
Accounts payable and accrued expenses	(21,702)	(18,576)
Contract liabilities	8,158	(1,907)
Refundable and accrued income taxes	7,590	4,238
Operating lease liability	(3,101)	(3,333)
Prepaid expenses and other current assets	(6,608)	(2,968)
Net cash provided (used) by operating activities	21,287	(30,462)
Investing Activities
Capital expenditures	(7,398)	(5,125)
Proceeds from sales of property, plant and equipment	66	4,087
Sales/maturities of marketable securities	400	100
Net cash used by investing activities	(6,932)	(938)
Financing Activities
Borrowings on line of credit	105,852	161,000
Repayment on debt	0	(1,000)
Payments on line of credit	(105,000)	(62,000)
Repurchase and retirement of common stock	(5,193)	(74,312)
Dividends paid	(5,245)	(4,793)
Other, net	(1,677)	(1,271)
Net cash (used) provided by financing activities	(11,263)	17,624
Increase (decrease) in cash, cash equivalents and restricted cash	3,092	(13,776)
Effect of exchange rates on cash	77	64
Cash, cash equivalents and restricted cash at beginning of year	21,473	37,583
Cash, cash equivalents and restricted cash at end of period	24,642	23,871
Noncash Activity
Capital expenditures in accounts payable	$ 2,115	$ 766